Strattera vs. stimulants: what a non-stimulant can and can't do

comparison · 6 min read

Strattera (atomoxetine) is usually the first name that comes up when stimulants aren't an option — and the most common mistake is expecting it to feel like a stimulant that just works less. It's a different kind of medication with a different job, and judging it by stimulant rules leads people to quit it exactly when it's starting to work.

A different mechanism, a different clock

Stimulants act within an hour and leave the same day. Atomoxetine is a norepinephrine reuptake inhibitor that builds effect gradually over two to six weeks of daily dosing — closer to how an antidepressant establishes itself than how Adderall kicks in. The payoff for the wait: coverage is around the clock, every day, with no wear-off cliff at 4 pm, no rebound, and nothing to time around meals.

The honest effect-size comparison

In trials, stimulants help roughly 70–80% of people with ADHD and carry the largest effect sizes in psychiatry. Atomoxetine's average effect is real but smaller — meaningfully helpful for many, transformative for some, insufficient alone for others. That's why it's usually a second-line choice rather than a downgrade: for the right person it's the better fit, not the weaker option.

Who tends to pick it

• Anxiety alongside ADHD — stimulants can sharpen anxiety; atomoxetine often doesn't, and sometimes helps it.
• Tics, or a history where a controlled substance is a problem — atomoxetine isn't a scheduled drug: no monthly prescription hoops, no shortage lottery, refills like any other medication.
• Evening and early-morning symptoms — 24-hour coverage reaches the hours a stimulant never touches.
• Stimulant side effects — appetite loss, sleep problems, or blood-pressure issues that didn't resolve with dose changes.

Why the converter won't convert it

There is no equivalence math between stimulants and atomoxetine — different mechanism, different dosing logic (it's titrated by body weight and response, typically 40 mg starting and 80 mg target in adults). That's why the converter deliberately shows "no stimulant dose equivalent" instead of inventing a number. Switching means starting fresh with your prescriber, and often means running both during a crossover period.

Educational content, not medical advice — medication choices belong with your prescriber.